INC Research/inVentiv Health Reports Third Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
INC Research Holdings (INCR) PT Lowered to $46 at Baird Following 3Q Miss
November 10, 2017 9:16 AM ESTBaird lowered its price target on INC Research Holdings (NASDAQ: INCR) to $46.00 (from $67.00) while maintaining a Outperform rating following 3Q. Pro forma adjusted revenue of $767M was down 2%/6% QQ/YY and missed estimates by 1%. Pro forma adjusted EBITDA of $139M... More



